This tracker provides information about the actions of federal agencies, such as the FDA and the USDA, on public health issues within the focus areas of the Center.

Displaying 1 - 13 of 13

Harmful and Potentially Harmful Constituents in Tobacco Products and Tobacco Smoke

In 2012, the FDA issued an established list of harmful and potentially harmful constituents to tobacco products. A proposed amendment to the original notice adding additional constituents to the proposed list, primarily reflecting upon those constituents to e-liquids, electronic cigarettes, and other novel tobacco products, was issued in 2019.

Tobacco Product Standard for Nicotine Level of Combusted Cigarettes

In 2018 the FDA issued an advance notice of proposed rulemaking (ANPRM) regarding setting a maximum limit on permissible nicotine levels in some or all tobacco products. Preliminary research suggested a lower nicotine ceiling could make initiation to tobacco products less likely and cessation easier, especially for youth and young adults.

Regulation of Flavors in Tobacco Products

In 2018, the FDA issued an advance notice of proposed rulemaking (ANPRM) regarding the regulation and restriction of flavored tobacco products. The ANPRM sought information and comments on 1) whether and how flavors attracted youth to initiate tobacco product use, and 2) whether and how flavors may help adult consumers reduce cigarette use and "switch to potentially less harmful" products.

Regulation of Premium Cigars

The FDA issued an advance notice of proposed rulemaking (ANPRM) in 2018, regarding the proposed regulation on premium cigars. FDA had deemed premium cigars within the scope of its regulatory authority for tobacco products in 2016, and thereby sought additional comments and research input pertinent to 1) the definition for premium cigars, 2) use patterns for premium cigars, and 3) public health considerations specific to, or otherwise pertinent to, premium cigars.

Premarket Tobacco Applications and Recordkeeping Requirements

In 2019, the FDA proposed a rule that would set forth requirements for premarket tobacco product applications (PMTAs) and would require manufacturers to maintain records establishing that their tobacco products are legally marketed. The objective of this rule is to provide FDA with sufficient information to make a determination on a preliminary PMTA for further, more substantive review or not.

Menthol in Cigarettes, Tobacco Products: Request for Comments

The FDA issued an ANPRM seeking feedback on potential regulation of menthol cigarettes. Under its statutory authority, FDA is empowered to regulate, and restrict, the sale of tobacco products if the agency determines that such a regulation is appropriate for the protection of public health.